Edition:
United States

Grifols SA (GRFS.OQ)

GRFS.OQ on NASDAQ Stock Exchange Global Select Market

19.23USD
12 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$19.23
Open
$19.22
Day's High
$19.53
Day's Low
$19.15
Volume
439,334
Avg. Vol
242,588
52-wk High
$25.17
52-wk Low
$17.48

Chart for

About

No overview information found for .

Overall

No Ratios Available.

Financials

  GRFS.OQ Industry Sector
P/E (TTM): -- 31.13 34.39
EPS (TTM): -- -- --
ROI: -- 15.55 14.96
ROE: -- 16.92 16.52

BRIEF-Grifols Says AMBAR Results Show Reduction In Progression of Moderate Alzheimer's Disease

* SAID ON SATURDAY THAT AMBAR CLINICAL TRIAL DEMONSTRATED THE ABILITY TO SLOW DOWN THE PROGRESSION OF THE DISEASE IN MODERATE ALZHEIMER'S DISEASE (AD) PATIENTS

Oct 29 2018

Spanish stocks - Factors to watch on Thursday

The following Spanish stocks may be affected by newspaper reports and other factors on Thursday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy:

Oct 11 2018

Healthcare firm Grifols S.A. wins U.S. antitrust nod to buy Biotest US Corp

WASHINGTON Global healthcare company, Grifols S.A. , which is based in Spain, has won U.S. antitrust approval to buy Biotest US Corp on condition that it sells certain assets, the Federal Trade Commission said on Wednesday.

Aug 01 2018

Healthcare firm Grifols S.A. wins US antitrust nod to buy Biotest US Corp

WASHINGTON, Aug 1 Global healthcare company, Grifols S.A., which is based in Spain, has won U.S. antitrust approval to buy Biotest US Corp on condition that it sells certain assets, the Federal Trade Commission said on Wednesday.

Aug 01 2018

Earnings vs. Estimates